MEG3 and acute myeloid leukemia: The results (Figure 5) indicated that high expression of lncRNA TUG1 and low expression of lncRNA MEG3 were associated with a reduced EFS in AML patients (HR = 1.51, 95%CI 1.19–1.90, P = 0.001), with a statistically significant difference.